Fate Therapeutics Adds Pratik Multani, M.D., M.S., as Vice President Clinical Development to Advance Upcoming Clinical Programs of Stem Cell ... (led to the identification of small molec...)

HOME >> MEDICINE >> NEWS

Fate Therapeutics Adds Pratik Multani, M.D., M.S., as Vice President Clinical Development to Advance Upcoming Clinical Programs of Stem Cell Modulators

Date:5/18/2009

led to the identification of small molecules and biologics that can direct stem cell proliferation and function. Fate Therapeutics is developing these small molecule and biologic SCMs to modulate the activity of adult stem cells to stimulate healing or block cancer growth.

"Fate's distinct and unique approach of using small molecules and biologics in stem cell medicine provides a well-defined regulatory path and allows the Company to move quickly into clinical programs to ultimately meet the needs of patients," said Dr. Multani. "This role represents to me one of the most exciting in the industry as we are applying the power of small molecule and biologic drug development, where we can use clearly defined safety and efficacy endpoints, to the revolutionary field of stem cell biology in order to develop new medicines for diseases and conditions that currently have limited to no treatment options."

Prior to joining Fate Therapeutics, Dr. Multani was Vice President of Translational Medicine at Kalypsys, Inc. since 2007, where he advanced the development of multiple compounds in the therapeutic areas of pain and inflammation and metabolic diseases. From 2005 to 2007 as Senior Vice President of Clinical Development and then Chief Medical Officer at Kanisa Pharmaceuticals, Dr. Multani led the clinical development of zosuquidar as well as a companion diagnostic in acute myeloid leukemia. From 2004 to 2005 as Vice President of Clinical Development at Salmedix, he led three clinical development programs in hematologic malignancies and solid tumors. From 1999 to 2004 advancing from Associate Director of Oncology and Hematology to Senior Director of Medical Research at Biogen-Idec, Dr. Multani led or provided strategic direction for multiple drug development programs in Phase 1 to Phase 4 clinical trials, including Zevalin(R) and Rituxan(R).

Before his career in industry, Dr. Multani held academic and clinical positi
'/>"/>

SOURCE Fate Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. ImQuest BioSciences and Arisyn Therapeutics Introduce Novel New HCV Therapeutic Agent at Hepatitis Conference
2. Nile Therapeutics Reports 2009 First Quarter Financial Results
3. Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With Naval Medical Research Center and Walter Reed Army Institute of Research
4. Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results
5. Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference
6. Nektar Therapeutics to Present at the Deutsche Bank 34th Annual Health Care Conference in Boston
7. Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2009 Financial Results on Wednesday, May 13th, at 4:30 P.M. EST
8. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $20 Million of Common Stock and Warrants
9. Cell Therapeutics, Inc. Intends to Offer to Exchange up to $89.2 Million of its Outstanding Convertible Notes in a Modified Dutch Auction Tender Offer
10. Cornerstone Therapeutics Reports First Quarter 2009 Financial Results
11. Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA

Post Your Comments:

(Date:5/24/2013)... Denver, CO (PRWEB) May 24, 2013 ... SEO analysis, in partnership with JD Media Surge, a ... , The dental SEO analysis service will focus ... high in the search engines for their competitive keywords. ... the dentists website and recommendations based on what their ...

(Date:5/24/2013)... (PRWEB) May 24, 2013 Gift ... Cards, major competitors in sustainable card material, are ... using forest materials as a sustainable gift card ... to identify industry challenges and increase education and ... programs to support the reduction of carbon footprint ...

(Date:5/24/2013)... Started in 1982, AMTC’s SHINE event is ... marks AMTC’s 31st anniversary. SHINE is a ministry run by ... Lewis and her daughter, Carey Lewis Arban. , This summer’s ... and music professionals including the New York Film Academy, The ... are kings of Hollywood and Christian casting directors. They seek ...

(Date:5/24/2013)... failed to replicate what appeared to be breakthrough results ... were published last year in the journal Science ... suggested that the drug bexarotene (marketed as Targretin) could ... a pathological hallmark of Alzheimer,s disease in ... the 2012 report, drug treatment quickly removed most of ...

(Date:5/24/2013)... 24, 2013 Amirsys today announces the ... enhancements for instructors and students. Instructors can use the ... personalize learning plan templates, targeted reading assignments, and customized ... new assessment questions, 5,000 searchable anatomy glossary terms, and ... AnatomyOne 2.0 is the first gross anatomy resource ...

Breaking Medicine News(10 mins):Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2 Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2 Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3 Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2 Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2 Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3 Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2

[0] Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge [0] Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants [0] AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 [0] Multiple research teams unable to confirm high-profile Alzheimer's study [0] Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans

... called ,phenomenal, study concludes , , WEDNESDAY, Sept. 24 (HealthDay ... retinal damage that leads to vision loss, according to ... of this drug on retinal health are phenomenal," Dr. ... the Vision Discovery Institute at MCG,s School of Medicine, ...

... Sept. 24 For the first time, ... reproductive cancer, especially,ovarian and uterine (endometrial) cancers, ... gynecologic oncologist. The 2008 State of the ... the Women of America,published by the Gynecologic ...

... the Disposable flexfit (TM) Breaks down Longstanding Barriers to ... ... 24 Songbird Hearing, Inc.,today introduces a unique option for people ... million Americans currently,experience some degree of hearing loss, while concerns about ...

... and his wife Tiffany, to Link Pediatric Critical Care to ... Children in New England and the Dominican Republic, BOSTON, ... are proud to announce the inaugural David Ortiz Celebrity,Golf Classic ... directly supports the David Ortiz Children,s Fund which,is dedicated to ...

... , ... Nashville, TN (Vocus) September 24, 2008 -- ... on Monday, September 29 at 9 a.m. with an outdoor ceremony ... The first two non African-American graduates of Meharry will be honored ...

... positive impact of transparency initiative, SOUTH ... Associates,Inc., the health care industry,s leading provider ... an unprecedented improvement in,patient satisfaction -- a ... of hospital-by-hospital satisfaction scores., Press Ganey ...

Cached Medicine News:Health News:Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist 2 Health News:Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist 3 Health News:Songbird Hearing Provides Revolutionary Alternative for Those Dealing With Hearing Loss 2 Health News:Songbird Hearing Provides Revolutionary Alternative for Those Dealing With Hearing Loss 3 Health News:Ortiz to Host Celebrity Golf Tournament to Benefit The David Ortiz Children's Fund 2 Health News:First Two Non African-American Graduates of Meharry Medical College to Receive Awards at 2008 Fall Convocation 2 Health News:First Two Non African-American Graduates of Meharry Medical College to Receive Awards at 2008 Fall Convocation 3 Health News:First Two Non African-American Graduates of Meharry Medical College to Receive Awards at 2008 Fall Convocation 4 Health News:Unprecedented Spike in Patient Satisfaction Follows Launch of Public Reporting 2 Health News:Unprecedented Spike in Patient Satisfaction Follows Launch of Public Reporting 3

Painkiller May Prevent Diabetes-Related Retinal Damage Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist Songbird Hearing Provides Revolutionary Alternative for Those Dealing With Hearing Loss Ortiz to Host Celebrity Golf Tournament to Benefit The David Ortiz Children's Fund First Two Non African-American Graduates of Meharry Medical College to Receive Awards at 2008 Fall Convocation Unprecedented Spike in Patient Satisfaction Follows Launch of Public Reporting

(Date:5/23/2013)... BRAINTREE, Mass. , May 23, 2013 Haemonetics Corporation ... Chris Lindop , CFO & EVP-Business Development, will present ... Care Conference in Boston, MA on ... (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may ... About Haemonetics Haemonetics (NYSE: ...

(Date:5/23/2013)... A recently published clinical study conducted at TOPS ... , demonstrates that 3D mammography (breast tomosynthesis) significantly reduces ... The study, "Implementation of Breast Tomosynthesis in a ... Stephen L. Rose , MD, and ... Journal of Roentgenology (AJR). The AJR is the ...

(Date:5/23/2013)... SAN DIEGO , May 23, 2013 /PRNewswire/ ... the prostate cancer treatment continuum was highlighted prominently ... the American Urological Association (AUA), in San Diego. ... invasive high intensity focused ultrasound (HIFU) technology, the ... localize disease, and for urologists to consider minimally ...

Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2 First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6

[0] Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference [0] First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams [0] Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting

... , CHICAGO, Nov. 28 Siemens ... ® (Total imaging matrix) technology and with its new ... the new MAGNETOM ® Aera* 1.5 Tesla (T) and ... Assembly and Annual Meeting of the Radiological Society of North ...

... , JOHANNESBURG, South Africa, Nov. 26 The ... Year Award in the Generic Pharmaceutical Market is presented ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , For the Company of the Year ... Medpro,s performance against key competitors: growth strategy and implementation, ...

Cached Medicine Technology:Siemens Introduces Its New Power Couple at RSNA 2009 2 Siemens Introduces Its New Power Couple at RSNA 2009 3 Siemens Introduces Its New Power Couple at RSNA 2009 4 Siemens Introduces Its New Power Couple at RSNA 2009 5 Siemens Introduces Its New Power Couple at RSNA 2009 6 Siemens Introduces Its New Power Couple at RSNA 2009 7 Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2 Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3 Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4

Siemens Introduces Its New Power Couple at RSNA 2009 Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market

PTC-100 cycler with Hot Bonnet heated lid,holds sixty 0.5ml tubes...

... PCR Sprint with 24-well x 0.2ml ... lid (includes tube thermistor) Heating rates: up ... control from 4-99C; Excellent uniformity: better than ... Easy to use programming: directory program storage ...

... instrument engineered to match the speed of ... system is based on heat transfer by ... tubes or thin walled micorcentrifuge tubes. Heating ... high velocity air results in nearly instantaneous ...

... Mx3005P instrument and custom filter wheels ... filters. The standard filter set includes: ... ROX/Texas Red (585nm-610nm), Cy5 (635nm-665nm) and ... computer, Mx3005P analysis software, Beacon Designer ...

Medicine Products:

PTC-100 cycler PCR Sprint Thermal Cycler RapidCycler Instrument Mx3005P Real-Time System (230v) with notebook computer